Product Details
Cosentyx Snrdy 300Mg Dose-2Pen
Manufacturer: Novartis
MFG#: 00078-0639-41
NDC: 00078-0639-41
PID: 340979
Additional Information
| Product Name | Cosentyx Sensoready 300 mg Dose- 2 Pen |
| Application | Treatment of Autoimmune Inflammatory Diseases |
| Active Ingredient | Secukinumab |
| Mechanism of Action | Inhibits Interleukin-17A (IL-17A) to reduce inflammation and immune response |
| Dosage Form | Injectable Solution |
| Strength | 300 mg/mL |
| Administration Route | Subcutaneous Injection |
| Dosing Schedule | Weekly for 5 weeks (loading phase), then every 4 weeks (maintenance) |
| Common Side Effects | Upper respiratory infections, headache, diarrhea, injection site reactions |
| Precautions | Increased infection risk; tuberculosis screening required before treatment |
| Packaging | Box containing 2 single-dose prefilled Sensoready Pen |
| Uses | Treatment of moderate to severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis |
Description
Cosentyx Sensoready 300 mg Pen is a biologic medication indicated for the treatment of moderate to severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis. It is a fully human monoclonal antibody that selectively inhibits interleukin-17A (IL-17A), a pro-inflammatory cytokine involved in the pathogenesis of autoimmune disorders.
The active ingredient, secukinumab, binds specifically to IL-17A and prevents its interaction with cellular receptors, thereby inhibiting the inflammatory cascade that leads to skin and joint damage. This targeted mechanism offers a highly effective and precise therapeutic approach compared to traditional systemic treatments.
Cosentyx Sensoready Pen is a prefilled autoinjector designed for subcutaneous administration. The initial dosing regimen consists of weekly injections for the first five weeks, followed by maintenance dosing every four weeks. The pen allows for self-administration in the thigh, abdomen, or upper arm, with site rotation recommended to minimize injection site reactions.
Frequently Asked Questions (FAQs)
The cost of Cosentyx Snrdy 300Mg Dose-2Pen is $available for registerd members only
Cosentyx Snrdy 300Mg Dose-2Pen is manufactured by Novartis.
You can purchase Cosentyx Snrdy 300Mg Dose-2Pen on our website at https://supplies.pipelinemedical.com/product/detail/cosentyx-syg-150mg-ml-2-sensoready-pen-340979